238 related articles for article (PubMed ID: 26492560)
61. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
62. [Use of monoclonal antibodies in prophylaxis and treatment of acute and chronic graft-versus-host disease in 2011].
Xhaard A; Hermet E; Bay JO; Peffault de Latour R
Bull Cancer; 2011 Aug; 98(8):889-99. PubMed ID: 21835730
[TBL] [Abstract][Full Text] [Related]
63. Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.
Pechey V; Parratt J; Vo L; Stevenson W
Int J Hematol; 2015 Feb; 101(2):203-6. PubMed ID: 25416235
[TBL] [Abstract][Full Text] [Related]
64. Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience.
Miano M; Cuzzubbo D; Terranova P; Giardino S; Lanino E; Morreale G; Castagnola E; Dini G; Faraci M
Bone Marrow Transplant; 2009 Mar; 43(5):423-7. PubMed ID: 18850021
[TBL] [Abstract][Full Text] [Related]
65. Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.
Matthews K; Lim Z; Pearce L; Pagliuca A; Alejandro Madrigal J; Mufti GJ; Barber LD
Br J Haematol; 2010 Jun; 149(6):879-89. PubMed ID: 20346011
[TBL] [Abstract][Full Text] [Related]
66. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
[TBL] [Abstract][Full Text] [Related]
67. The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study.
Becker MO; Brückner C; Scherer HU; Wassermann N; Humrich JY; Hanitsch LG; Schneider U; Kawald A; Hanke K; Burmester GR; Riemekasten G
Ann Rheum Dis; 2011 Jul; 70(7):1340-1. PubMed ID: 21068100
[No Abstract] [Full Text] [Related]
68. Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease.
van Groningen LF; Liefferink AM; de Haan AF; Schaap NP; Donnelly JP; Blijlevens NM; van der Velden WJ
Biol Blood Marrow Transplant; 2016 Jan; 22(1):179-82. PubMed ID: 26386320
[TBL] [Abstract][Full Text] [Related]
69. Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease.
Nogueira MC; Azevedo AM; Pereira SC; Ferreira JL; Lerner D; Lobo AM; Tavares RC; Tabak DG; Lorenzi N; Renault IZ; Bouzas LF
Braz J Med Biol Res; 2007 Dec; 40(12):1623-9. PubMed ID: 17713663
[TBL] [Abstract][Full Text] [Related]
70. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
[TBL] [Abstract][Full Text] [Related]
71. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
[TBL] [Abstract][Full Text] [Related]
72. Ruxolitinib treatment for steroid refractory acute and chronic graft vs host disease in children: Clinical and immunological results.
González Vicent M; Molina B; González de Pablo J; Castillo A; Díaz MÁ
Am J Hematol; 2019 Mar; 94(3):319-326. PubMed ID: 30536806
[TBL] [Abstract][Full Text] [Related]
73. A new induction protocol for the control of steroid refractory/dependent acute graft versus host disease with alefacept and tacrolimus.
Shapira MY; Resnick IB; Dray L; Aker M; Stepensky P; Elad S; Gesundeheidt B; Samuel S; Or R
Cytotherapy; 2009; 11(1):61-7. PubMed ID: 19191054
[TBL] [Abstract][Full Text] [Related]
74. Treatment of graft-versus-host disease after liver transplantation with basiliximab followed by bowel resection.
Sudhindran S; Taylor A; Delriviere L; Collins VP; Liu L; Taylor CJ; Alexander GJ; Gimson AE; Jamieson NV; Watson CJ; Gibbs P
Am J Transplant; 2003 Aug; 3(8):1024-9. PubMed ID: 12859540
[TBL] [Abstract][Full Text] [Related]
75. Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.
Cahn JY; Bordigoni P; Tiberghien P; Milpied N; Brion A; Widjenes J; Lioure B; Michel G; Burdach S; Kolb HJ
Transplantation; 1995 Nov; 60(9):939-42. PubMed ID: 7491697
[TBL] [Abstract][Full Text] [Related]
76. Low-dose alemtuzumab vs. standard policy for prevention of graft-versus-host disease in unrelated and related allogeneic stem cell transplantation-a matched pair analysis.
Busemann C; Neumann T; Schulze M; Klenner A; Thiele T; Greinacher A; Dölken G; Krüger WH
Ann Hematol; 2013 Jul; 92(7):945-52. PubMed ID: 23463451
[TBL] [Abstract][Full Text] [Related]
77. [Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].
Yang K; Fan ZP; Liu QF; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):537-41. PubMed ID: 18495584
[TBL] [Abstract][Full Text] [Related]
78. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
[TBL] [Abstract][Full Text] [Related]
79. The use of basiliximab-infliximab combination for the treatment of severe gastrointestinal acute GvHD.
Nadeau M; Perreault S; Seropian S; Foss F; Isufi I; Cooper DL
Bone Marrow Transplant; 2016 Feb; 51(2):273-6. PubMed ID: 26479982
[TBL] [Abstract][Full Text] [Related]
80. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
Front Immunol; 2021; 12():678476. PubMed ID: 34220825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
